Hangzhou LLE Biopharma

LLE Biopharma is a clinical-stage biopharmaceutical company based in Hangzhou, China, specializing in the development of innovative topical and high-barrier generic drugs. The company leverages its proprietary crystal engineering and advanced formulation platforms to optimize the delivery and efficacy of small molecule therapeutics, particularly for dermatological and inflammatory conditions. Its pipeline includes several novel JAK inhibitors and PDE4 inhibitors designed for local application to minimize systemic side effects. LLE Biopharma aims to address unmet medical needs in skin diseases such as atopic dermatitis and psoriasis through precision drug delivery and improved bioavailability.